These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [The use of allogeneic bone marrow transplantation and immunosuppressive therapy in the treatment of patients with acquired aplastic anemia]. Ganapiev AA; Golubovskaia IK; Zalialov IuR; Estrina MA; Afanas'ev BV Ter Arkh; 2010; 82(7):48-52. PubMed ID: 20853609 [TBL] [Abstract][Full Text] [Related]
6. The role of haplo-identical bone marrow transfusion in ALG treated patients with severe aplastic anemia (SAA). Weber W; Speck B; Cornu P; Nissen C; Jeannet M Haematol Blood Transfus; 1979; 24():193-7. PubMed ID: 396174 [No Abstract] [Full Text] [Related]
7. [Pathogenesis and treatment of aplastic anemia. Recent advances]. Nomura T Nihon Ika Daigaku Zasshi; 1985 Dec; 52(6):613-23. PubMed ID: 3912403 [No Abstract] [Full Text] [Related]
8. [Transplantation of the bone marrow from a HLA-compatible unrelated donor after immunoablative conditioning in children with acquired aplastic anemia unresponsive to combined immunosuppressive therapy: preliminary results]. Novichkova GA; Maschan MA; Shipitsyna IP; Skvortsova IuV; Persiantseva MI; Lebedeva LL; Bobrynina VO; Baĭdil'dina DD; Goronkova OV; Solopova GG; Khachatrian LA; Petrova UN; Suntsova EV; Kalinina II; Sinitsyna VV; Skorobogatova EV; Balashov DN; Dyshlevaia ZM; Shelikhova LN; Kurnikova EE; Trakhtman PE; Maschan AA Ter Arkh; 2010; 82(7):41-7. PubMed ID: 20853608 [TBL] [Abstract][Full Text] [Related]
9. Antilymphocyte globulin as the sole immunosuppressant for bone marrow transplantation in aplastic anemia. A case report. Rogentine GN; Rosenberg EB; Merritt CB; Rosenberg SA; Yankee RA; Graw RG; Greipp P; Whang-Peng J; Fahey JL Transplantation; 1973 May; 15(5):514-7. PubMed ID: 4575740 [No Abstract] [Full Text] [Related]
10. Treatment of aplastic anemia. Gale RP Tokai J Exp Clin Med; 1985 Jun; 10(2-3):117-26. PubMed ID: 3914736 [No Abstract] [Full Text] [Related]
11. "Myelophrenia": its contribution to the management of aplastic anemia. Nathan DG Prog Clin Biol Res; 1984; 148():xxi-xxx. PubMed ID: 6379655 [No Abstract] [Full Text] [Related]
12. Lymphocytes and lymphokines in aplastic anemia: pathogenic role and implications for pathogenesis. Young NS; Leonard E; Platanias L Blood Cells; 1987; 13(1-2):87-100. PubMed ID: 3311225 [TBL] [Abstract][Full Text] [Related]
13. [The human bone marrow transplant. II. The transplant in aplastic anemia]. Izzi T; Lucarelli G Recenti Prog Med; 1983 Feb; 74(2):199-213. PubMed ID: 6346419 [No Abstract] [Full Text] [Related]
14. Rationale for the use of ALG as sole immunosuppressant in allogeneic bone marrow transplantation for aplastic anemia. Speck B; Buckner CD; Cornu P; Jeannet B Transplant Proc; 1976 Dec; 8(4):617-22. PubMed ID: 11593 [No Abstract] [Full Text] [Related]
15. A comparison between ALG and bone marrow transplantation in treatment of severe aplastic anemia. Speck B; Gratwohl A; Nissen C; Osterwalder B; Würsch A; Tichelli A; Lori A; Reusser P; Jeannet M; Signer E Thymus; 1987; 10(1-2):147-58. PubMed ID: 3324403 [TBL] [Abstract][Full Text] [Related]
16. [Bone marrow transplantation and (or) immunosuppression with antithymocyte globulin in the treatment of aplastic anemia]. Zwaan FE; Haak HL; van der Meer CW; Guiot HF; Hartgrink-Groeneveld CA; den Ottolander GJ; Willemze R; Eernisse JG; Brand A; van Rood JJ; Kunst MW; te Velde J; Noordwijk EM Ned Tijdschr Geneeskd; 1978 Mar; 122(10):326-32. PubMed ID: 24811 [No Abstract] [Full Text] [Related]
17. [Immunopathogenesis of aplastic anemia]. Speck B Internist (Berl); 1979 Oct; 20(10):502-5. PubMed ID: 389876 [No Abstract] [Full Text] [Related]